Journey Medical Corporation
DERM
$6.33
$0.081.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.73% | -1.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.90% | -1.52% | |||
| Cost of Revenue | -57.67% | -19.20% | |||
| Gross Profit | 21.82% | 12.39% | |||
| SG&A Expenses | -11.72% | 10.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.02% | -1.46% | |||
| Operating Income | 177.19% | 1.13% | |||
| Income Before Tax | 166.19% | 28.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 163.64% | 28.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 163.64% | 28.89% | |||
| EBIT | 177.19% | 1.13% | |||
| EBITDA | 254.57% | 1.52% | |||
| EPS Basic | 161.34% | 30.76% | |||
| Normalized Basic EPS | 143.36% | -1.81% | |||
| EPS Diluted | 156.25% | 28.61% | |||
| Normalized Diluted EPS | 143.36% | -1.81% | |||
| Average Basic Shares Outstanding | 3.77% | 2.72% | |||
| Average Diluted Shares Outstanding | 3.77% | 2.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||